Oxford BioMedica Oxford BioMedica is a niche specialist in gene and cell therapy, with a leading position in lentiviral and cell therapy research, development and bioprocessing.
|Admission date:||29 May 2018|
No Results & Reports data for this company
|20 Sep 2023||Extended Analyst and Investor Briefing|
|23 Jun 2023||Annual General Meeting|
|25 Apr 2023||Analyst Briefing|
|20 Apr 2023||Analyst Briefing and Q&A Session|
|15 Sep 2022||Virtual Analyst Briefing|